03/20/2026

[Duplicate] WPS Oncology Related LCD Updates

New Policy Updates

March 2026 Local Coverage Determination (LCD) and Billing and Coding Article Updates 

We updated the following Local Coverage Determinations (LCDs) and Billing and Coding Articles for March 2026. The full article on our website details additional information on these updates.  

Please note: Our LCDs and Billing and Coding/Coverage articles will reflect these changes on February 26, 2026.

New Policies/Articles – We created no new policies/articles for March 2026. 

Retired Policies/Articles – We retired the following policies/articles for March 2026 – Effective February 21, 2026:

• Billing and Coding: Botulinum Toxin Type A & Type B 
• Botulinum Toxin Type A & Type B

Revised Policies/Articles – We revised the following policies/articles for March 2026 – Effective as Indicated 

• Billing and Coding: Botulinum Toxin Injections – Effective February 22, 2026 
• Billing and Coding: Immune Globulins – Effective February 26, 2026 
• Billing and Coding: Non-Invasive Abdominal / Visceral Vascular Studies – Effective February 26, 2026 
• Independent Diagnostic Testing Facilities- Physician Supervision and Technician Requirements – Effective January 1, 2026